Status:
COMPLETED
Ondansetron Treatment for Alcoholism
Lead Sponsor:
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Conditions:
Alcoholism
Eligibility:
All Genders
25-60 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to: a) evaluate the effectiveness of ondansetron (Zofran) in the treatment of alcohol dependent patients; b) investigate whether early versus late onset alcoholism predict...
Eligibility Criteria
Inclusion Criteria:
- Meet criteria for alcohol dependence.
- Subjects with early onset alcoholism must also have a diagnosis of antisocial personality disorder.
- Understand the requirements of the study and be able to complete the questionnaires and rating scales.
Exclusion Criteria:
- Current diagnosis of substance dependence or self-report of having used narcotics (opiates, cocaine, amphetamine-like substances, and hallucinogens) in the 30 day period prior to study.
- Positive urine drug screen test for narcotics, barbiturates, or benzodiazepines.
- Receiving current psychotropic medications.
- Current history of other psychiatric disorders excluding nicotine dependence.
- Hepatocellular disease.
- Pregnant females.
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
End Date :
April 1 2000
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00000443
End Date
April 1 2000
Last Update
June 24 2005
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Substance Abuse Research Center, University of Texas Health Science Center
Houston, Texas, United States, 77030